C. Thornsberry

发表

Evaluation of Current Activities of Fluoroquinolones against Gram-Negative Bacilli Using Centralized In Vitro Testing and Electronic Surveillance

J. Karlowsky, D. Sahm, I. Critchley, 2001, Antimicrobial Agents and Chemotherapy.

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network.

A. Evangelista, J. Karlowsky, D. Sahm, 2002, International journal of antimicrobial agents.

Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005.

A. Evangelista, D. Sahm, C. Thornsberry, 2008, Postgraduate medicine.

Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of Temperature on the In Vitro Susceptibility of Staphylococcus aureus to Penicillinase-Resistant Penicillins

C. Baker, C. Thornsberry, J. Caruthers, 1973, Antimicrobial Agents and Chemotherapy.

Surveillance of Antimicrobial Resistance among Respiratory Tract Pathogens in the United States, 1997 to 1998

D. Sahm, J. Kahn, C. Thornsberry, 1999, Drugs.

Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.

C. Thornsberry, P. Burton, B. H. Vanderhoof, 1996, Diagnostic microbiology and infectious disease.

Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States

J. Karlowsky, D. Sahm, Mark E. Jones, 2002, Antimicrobial Agents and Chemotherapy.

Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999.

J. Karlowsky, M. Jones, D. Sahm, 2001, International journal of antimicrobial agents.

Antimicrobial Resistance Among Escherichia coli Urinary Tract Isolates in the United States: A Current View Provided by Electronic Surveillance

J. Karlowsky, D. Sahm, D. Mayfield, 2001 .

Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth

D. Hollis, C. Baker, C. Thornsberry, 1985, Journal of clinical microbiology.

Trends in Antimicrobial Susceptibilities among Enterobacteriaceae Isolated from Hospitalized Patients in the United States from 1998 to 2001

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Antimicrobial Agents and Chemotherapy.

Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies.

A. Evangelista, J. Karlowsky, D. Sahm, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of Four Antimicrobial Susceptibility Testing Methods To Determine the In Vitro Activities of Piperacillin and Piperacillin-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Journal of Clinical Microbiology.

Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci

L. Mcdougal, C. Thornsberry, L. McDougal, 1983, Journal of clinical microbiology.

The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins

L. Mcdougal, C. Thornsberry, L. McDougal, 1986, Journal of clinical microbiology.

Laboratory Evaluation of a Rapid, Automated Susceptibility Testing System: Report of a Collaborative Study

A. Balows, J. Sherris, J. Washington, 1975, Antimicrobial Agents and Chemotherapy.

Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution

C. Thornsberry, J. Swenson, V. Silcox, 1982, Antimicrobial Agents and Chemotherapy.

Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan

D. Granoff, T. Mastro, R. Facklam, 1991, The Lancet.

Patterns and mechanisms of beta-lactam resistance among isolates of Escherichia coli from hospitals in the United States

É. Gay, R. Cooksey, N. Clark, 1990, Antimicrobial Agents and Chemotherapy.

Halophilic Vibrio species isolated from blood cultures

D. Hollis, R. Weaver, C. Baker, 1976, Journal of clinical microbiology.

Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics

R. Wallace,, C. Thornsberry, J. Swenson, 1983, Antimicrobial Agents and Chemotherapy.

Longitudinal Assessment of Antipneumococcal Susceptibility in the United States

J. Karlowsky, D. Sahm, I. Critchley, 2002, Antimicrobial Agents and Chemotherapy.

Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis

J. Karlowsky, D. Sahm, I. Critchley, 2001, Antimicrobial Agents and Chemotherapy.

Benchmarking the In Vitro Activities of Moxifloxacin and Comparator Agents against Recent Respiratory Isolates from 377 Medical Centers throughout the United States

D. Sahm, I. Critchley, Mark E. Jones, 2000, Antimicrobial Agents and Chemotherapy.

Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre study.

M. Jones, D. Sahm, I. Critchley, 2000, Diagnostic microbiology and infectious disease.

Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002.

J. Karlowsky, M. Jones, D. Sahm, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003

J. Karlowsky, D. Sahm, Mark E. Jones, 2004, Annals of Clinical Microbiology and Antimicrobials.

In Vitro Activities of Novel Nonfluorinated Quinolones PGE 9262932 and PGE 9509924 against Clinical Isolates of Staphylococcus aureus and Streptococcus pneumoniae with Defined Mutations in DNA Gyrase and Topoisomerase IV

J. Karlowsky, D. Sahm, I. Critchley, 2002, Antimicrobial Agents and Chemotherapy.

Antimicrobial Susceptibility of Five Subgroups of Mycobacterium fortuitum and Mycobacterium chelonae

R. Wallace,, C. Thornsberry, J. Swenson, 1986, Antimicrobial Agents and Chemotherapy.

Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae

C Thornsberry, R. Wallace,, C. Thornsberry, 1985, Antimicrobial Agents and Chemotherapy.

Antimicrobial Susceptibility ofFiveSubgroups ofMycobacterium fortuitum andMycobacterium chelonae

C. Thornsberry, Antimicrobics andInfection, 1985 .

In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin

R. Jones, A. Barry, C. Thornsberry, 1988, Antimicrobial Agents and Chemotherapy.

Prevalence of Acinetobacter spp. isolates with reduced susceptibility to imipenem, as determined by a USA-wide electronic surveillance network.

D. Livermore, M. Jones, D. Sahm, 1999, The Journal of antimicrobial chemotherapy.

Simple inoculum standardizing system for antimicrobial disk susceptibility tests

M. Coyle, A. Barry, D. Amsterdam, 1979, Journal of clinical microbiology.

Rapid determination of minimum inhibitory concentrations of antimicrobial agents by the Autobac method: a collaborative study

J. Washington, C. Thornsberry, F. Schoenknecht, 1980, Antimicrobial Agents and Chemotherapy.

Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

J. Kahn, C. Thornsberry, Y. Mauriz, 1997, Diagnostic microbiology and infectious disease.

New recommendations for disk diffusion antimicrobial susceptibility tests for methicillin-resistant (heteroresistant) staphylococci

L. Mcdougal, C. Thornsberry, L. McDougal, 1984, Journal of clinical microbiology.

Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002

J. Karlowsky, D. Sahm, Mark E. Jones, 2004, Annals of Clinical Microbiology and Antimicrobials.

In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy

R. Wenzel, J. Karlowsky, D. Sahm, 2003, Antimicrobial Agents and Chemotherapy.

Survey of Susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Isolates to 26 Antimicrobial Agents: a Prospective U.S. Study

D. Sahm, C. Thornsberry, H. Holley, 1999, Antimicrobial Agents and Chemotherapy.

Proposed disk diffusion susceptibility criteria for ofloxacin

R. Jones, A. Barry, P. Fuchs, 1985, Journal of clinical microbiology.

Transfer of Beta-Lactamase Genes of Neisseria gonorrhoeae by Conjugation

C. Thornsberry, L. A. Kirven, Clyde Thornsberry, 1977, Antimicrobial Agents and Chemotherapy.

Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents.

G. Doern, J. Jorgensen, C. Thornsberry, 1988, Diagnostic microbiology and infectious disease.

In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.

L. Ayers, R. Jones, A. Barry, 1986, Diagnostic microbiology and infectious disease.

Methods for determining susceptibility of fastidious and unusual pathogens to selected antimicrobial agents.

L. Mcdougal, C. Baker, C. Thornsberry, 1988, Diagnostic microbiology and infectious disease.

Susceptibility testing of fastidious and unusual pathogens

L. Mcdougal, C. Baker, C. Thornsberry, 1987 .

Disc agar diffusion antimicrobial susceptibility tests with beta-lactamase producing Neisseria gonorrhoeae.

C. Thornsberry, J. Swenson, J. Biddle, 1978, The Journal of antibiotics.

Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks

H. Neu, J. Washington, J. Anhalt, 1985, Journal of clinical microbiology.

Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.

A. Evangelista, J. Karlowsky, D. Sahm, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001

J. Karlowsky, D. Sahm, I. Critchley, 2003, Antimicrobial Agents and Chemotherapy.

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002).

A. Evangelista, J. Karlowsky, D. Sahm, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001.

J. Karlowsky, D. Sahm, I. Critchley, 2003, The Journal of antimicrobial chemotherapy.

In Vitro Activities of Broad-Spectrum Cephalosporins against Nonmeningeal Isolates of Streptococcus pneumoniae: MIC Interpretation Using NCCLS M100-S12 Recommendations

J. Karlowsky, D. Sahm, Mark E. Jones, 2002, Journal of Clinical Microbiology.

Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000.

J. Karlowsky, D. Sahm, I. Critchley, 2002, International journal of antimicrobial agents.

Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US.

J. Karlowsky, D. Sahm, I. Critchley, 2002, International journal of antimicrobial agents.

Levofloxacin-Resistant Streptococcus pneumoniae: Second Look

J. Karlowsky, D. Sahm, C. Thornsberry, 2001, Antimicrobial Agents and Chemotherapy.

In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation with penicillin resistance.

D. Sahm, C. Thornsberry, H. Holley, 1998, Clinical therapeutics.

A gene probe for TEM type beta-lactamases

R. Cooksey, N. Clark, C. Thornsberry, 1985, Antimicrobial Agents and Chemotherapy.

Factors Associated with Relative Rates of Antibiotic Resistance in Pseudomonas aeruginosa Isolates Tested in Clinical Laboratories in the United States from 1999 to 2002

J. Karlowsky, D. Sahm, R. Flamm, 2004, Antimicrobial Agents and Chemotherapy.

In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates

R. Jones, A. Barry, P. Fuchs, 1984, Antimicrobial Agents and Chemotherapy.

Susceptibilities to Levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United States

G. Noel, A. Evangelista, J. Karlowsky, 2003, Antimicrobial Agents and Chemotherapy.

Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98.

M. Jones, D. Sahm, H. Sader, 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle.

J. Leyden, C. Thornsberry, O. Mills, 2002, Acta dermato-venereologica.

Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability.

L. Ayers, R. Jones, A. Barry, 1985, Diagnostic microbiology and infectious disease.

Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999.

J. Karlowsky, D. Sahm, I. Critchley, 2002, Diagnostic microbiology and infectious disease.

In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.

A. Evangelista, J. Karlowsky, M. Jones, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Resistance in Respiratory Tract Pathogens: An International Study 1997–1998

D. Sahm, C. Thornsberry, 2000, Journal of chemotherapy.

In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin

R. Jones, A. Barry, C. Thornsberry, 1987, Antimicrobial Agents and Chemotherapy.

Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative.

J. Karlowsky, D. Sahm, I. Critchley, 2002, International journal of antimicrobial agents.

Analysis of Ciprofloxacin Activity against Streptococcus pneumoniae after 10 Years of Use in the United States

D. Sahm, I. Critchley, C. Thornsberry, 2000, Antimicrobial Agents and Chemotherapy.

Ampicillin Resistance in Haemophilus influenzae as Determined by a Rapid Test for Beta-Lactamase Production

C. Thornsberry, L. A. Kirven, 1974, Antimicrobial Agents and Chemotherapy.

Prevalence of gyrA, gyrB, parC, and parE Mutations in Clinical Isolates ofStreptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season

K. Köhrer, P. Heisig, D. Sahm, 2000, Antimicrobial Agents and Chemotherapy.

In-vitro studies of meropenem.

R. Jones, A. Barry, C. Thornsberry, 1989, The Journal of antimicrobial chemotherapy.

In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren.

J. Karlowsky, D. Sahm, I. Critchley, 2002, Diagnostic microbiology and infectious disease.

Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients

J. Karlowsky, J. Bradley, M. Jones, 2004, European Journal of Clinical Microbiology and Infectious Diseases.

Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001.

J. Karlowsky, M. Jones, D. Sahm, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Relationship between Antibiotic Resistance in Streptococcus pneumoniae and That in Haemophilus influenzae: Evidence for Common Selective Pressure

J. Karlowsky, D. Sahm, I. Critchley, 2002, Antimicrobial Agents and Chemotherapy.

Ceftriaxone activity against Gram-positive and Gram-negative pathogens isolated in US clinical microbiology laboratories from 1996 to 2000: results from The Surveillance Network (TSN) Database-USA.

J. Karlowsky, M. Jones, D. Sahm, 2002, International journal of antimicrobial agents.

Antimicrobial Resistance in Respiratory Tract Pathogens: Results of an International Surveillance Study

D. Sahm, C. Thornsberry, 2000, Chemotherapy.

The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002.

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Diagnostic microbiology and infectious disease.

Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem.

F. Aarestrup, P. McDermott, L. Piddock, 2004, Microbial drug resistance.

Susceptibility of Clostridium botulinum to thirteen antimicrobial agents

C. Hatheway, V. R. Dowell, C. Thornsberry, 1980, Antimicrobial Agents and Chemotherapy.

Screening pneumococci for penicillin resistance

C. Thornsberry, J. Swenson, B. Hill, 1986, Journal of clinical microbiology.

Interpretive criteria for temocillin disk diffusion susceptibility testing

R. Jones, A. Barry, P. Fuchs, 1985, European Journal of Clinical Microbiology.

Antibiotic Susceptibility of Streptococcus bovis and Other Group D Streptococci Causing Endocarditis

R. Facklam, C. Baker, C. Thornsberry, 1974, Antimicrobial Agents and Chemotherapy.

Antimicrobial Susceptibility of Streptococcus mutans Isolated from Patients with Endocarditis

C. Baker, C. Thornsberry, Clyde Thornsberry, 1974, Antimicrobial Agents and Chemotherapy.

Commercial detection methods for biotinylated gene probes: Comparison with32P-labeled DNA probes

R. Cooksey, C. Thornsberry, P. Zwadyk, 1986, Current Microbiology.

Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group

F. Tenover, R. Cooksey, R. Facklam, 1992, Journal of clinical microbiology.

In Vitro Activity of Antimicrobial Agents on Legionnaires Disease Bacterium

C. Baker, C. Thornsberry, L. A. Kirven, 1978, Antimicrobial Agents and Chemotherapy.

National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae

G. Doern, J. Jorgensen, C. Thornsberry, 1988, Antimicrobial Agents and Chemotherapy.

Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline

P. Murray, R. Jones, J. Washington, 1989, Journal of clinical microbiology.

Evaluating the in vitro susceptibility of bovine mastitis pathogens to a combination of kanamycin and cefalexin: Recommendations for a disk diffusion test.

C. Thornsberry, C. Pillar, L. Goby, 2009, Journal of dairy science.

Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model

R. J. Gibson, J. Feeley, C. D. Jeffries, 1985, Infection and immunity.

Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci

R. Facklam, C. Baker, C. Thornsberry, 1981, Antimicrobial Agents and Chemotherapy.

Invitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe

A. Evangelista, J. Karlowsky, M. Jones, 2014 .

Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000-2001: a comparison with other beta-lactam agents.

J. Karlowsky, D. Sahm, I. Critchley, 2003, The Journal of antimicrobial chemotherapy.

Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species

R. Facklam, C. Thornsberry, J. Swenson, 1990, Antimicrobial Agents and Chemotherapy.

DNA hybridization studies of a nucleotide sequence homologous to transposon Tn1545 in the "Minnesota" strain of multiresistant Streptococcus pneumoniae isolated in 1977.

R. Cooksey, N. Clark, C. Thornsberry, 1989, Diagnostic microbiology and infectious disease.

Antimicrobial Susceptibility of Subgingival Bacterial Flora in Dogs with Gingivitis

F. Shofer, C. Thornsberry, C. Harvey, 1995, Journal of veterinary dentistry.

A comparative study of the in-vitro activity of cefepime and other antimicrobial agents against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.

S. Brown, C. Thornsberry, Y. Yee, 1993, The Journal of antimicrobial chemotherapy.

Broth-Dilution Method for Determining the Antibiotic Susceptibility of Anaerobic Bacteria

C. Thornsberry, D. Stalons, 1975, Antimicrobial Agents and Chemotherapy.

Epidemiology of staphylococcal infections--a USA perspective.

C. Thornsberry, 1994, Journal of chemotherapy.

Antimicrobial Susceptibility Patterns of Common and Unusual Species of Enterococci Causing Infections in the United States

C. Hill, F. Tenover, R. Cooksey, 2022 .

Multidrug-Resistant Urinary Tract Isolates ofEscherichia coli: Prevalence and Patient Demographics in the United States in 2000

Clyde Thornsberry, J. Karlowsky, D. Sahm, 2001, Antimicrobial Agents and Chemotherapy.

Cefuroxime, a New Parenteral Cephalosporin: Collaborative In Vitro Susceptibility Comparison with Cephalothin Against 5,887 Clinical Bacterial Isolates

Ronald N. Jones, A. Barry, P. Fuchs, 1977, Antimicrobial Agents and Chemotherapy.

Methods ofMeasuring ZonesofInhibition withtheBauer- KirbyDiskSusceptibility Test

Clyde Thornsberry, C. Thornsberry, 1979 .

Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime

R. Jones, A. Barry, C. Thornsberry, 1989, Antimicrobial Agents and Chemotherapy.

Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks

R. Jones, A. Barry, C. Thornsberry, 1984, Journal of clinical microbiology.

Interpretive Standards andQuality Control Guidelines forImipenem Susceptibility Tests with10-Vig Disks

C. Thornsberry, 1984 .

In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests.

R. Jones, A. Barry, C. Thornsberry, 1989, The Journal of antimicrobial chemotherapy.

Activities of Faropenem, an Oral β-Lactam, against Recent U.S. Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

J. Karlowsky, D. Sahm, I. Critchley, 2002, Antimicrobial Agents and Chemotherapy.

Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test

P. Fernandes, J. Jorgensen, R. Jones, 1988, Journal of clinical microbiology.

Determining Linezolid’s Baseline In Vitro Activity in Canada Using Gram-Positive Clinical Isolates Collected prior to Its National Release

J. Karlowsky, D. Sahm, I. Critchley, 2002, Antimicrobial Agents and Chemotherapy.

In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.

K. Krause, D. Sahm, C. Thornsberry, 2008, The Journal of antimicrobial chemotherapy.

Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States

K. Krause, D. Sahm, C. Thornsberry, 2008, Antimicrobial Agents and Chemotherapy.

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy.

D. Nathwani, J. Karlowsky, D. Sahm, 2003, International journal of antimicrobial agents.

Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests

R. Jones, A. Barry, C. Baker, 1981, Antimicrobial Agents and Chemotherapy.

Resistance Mechanisms of Multiply Resistant Pneumococci: Antibiotic Degradation Studies

I. Wachsmuth, H. Koornhof, M. Jacobs, 1979, Antimicrobial Agents and Chemotherapy.

Inoculum standardization in antimicrobial susceptibility testing: evaluation of overnight agar cultures and the Rapid Inoculum Standardization System

C. Baker, C. Thornsberry, R. Hawkinson, 1983, Journal of clinical microbiology.

Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing

L. Ayers, R. Jones, A. Barry, 1982, Antimicrobial Agents and Chemotherapy.

Effect of Calcium and Magnesium Ions on the Susceptibility of Pseudomonas Species to Tetracycline, Gentamicin Polymyxin B, and Carbenicillin

C. Baker, C. Thornsberry, R. D'amato, 1975, Antimicrobial Agents and Chemotherapy.

Selection of a reference lot of Mueller-Hinton agar

A. Barry, P. Fuchs, H. Frankel, 1986, Journal of clinical microbiology.

Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteria.

C. Thornsberry, 1985, The American journal of medicine.

Determination of the ascorbic acid content of two medicinal plants in Nigeria.

L. Ayers, S. Brown, R. Jones, 2006 .

Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa

R. Jones, A. Barry, C. Thornsberry, 1984, Journal of Clinical Microbiology.

Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories

R. Jones, A. Barry, C. Thornsberry, 1981, Journal of clinical microbiology.

Medium-dependent zone size discrepancies associated with susceptibility testing of group D streptococci against various cephalosporins

R. Jones, D. Sahm, C. Baker, 1983, Journal of clinical microbiology.

Disk diffusion and disk elution tests with A-56268 and erythromycin

R. Jones, A. Barry, C. Thornsberry, 1987, European Journal of Clinical Microbiology.

Antimicrobial susceptibility testing of anaerobic bacteria: review and update on the role of the National Committee for Clinical Laboratory Standards.

C. Thornsberry, 1990, Reviews of infectious diseases.

Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods

R. Jones, A. Barry, P. Fuchs, 1986, Journal of clinical microbiology.

Preparing inoculum for susceptibility testing of anaerobes

C. Thornsberry, J. Swenson, 1984, Journal of Clinical Microbiology.

Problems with the disk diffusion test for detection of vancomycin resistance in enterococci

C. Thornsberry, J. Swenson, B. Hill, 1989, Journal of clinical microbiology.

Problems with the disk diffusion test for detection of vancomycin resistance in enterococci

C. Thornsberry, J. Swenson, B. Hill, 1989 .

NCCLS subcommittee members respond: To “Critical reflections on current problems associated with susceptibility testing and monitoring of antimicrobial therapy”

C. Stratton, J. Waitz, C. Thornsberry, 1987 .

Antimicrobial susceptibility testing systems past and present: A documented overview. Part II

M. Gradus, C. Baker, C. Thornsberry, 1985 .

Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis

R. Jones, D. Sahm, C. Baker, 1984, Journal of clinical microbiology.

Effect of media and blood on the antimicrobial activity of cephalosporins on serogroup D streptococci: a review.

D. Sahm, C. Thornsberry, 1984, Diagnostic microbiology and infectious disease.

Gram-positive superinfections: A consequence of modern β-lactam chemotheraphy

R. Jones, C. Thornsberry, 1985 .

Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response.

R. Jones, A. Barry, P. Fuchs, 1982, Reviews of infectious diseases.

Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing

R. Jones, A. Barry, P. Fuchs, 1980, Antimicrobial Agents and Chemotherapy.

Methods of measuring zones of inhibition with the Bauer-Kirby disk susceptibility test

M. Coyle, A. Barry, C. Thornsberry, 1979, Journal of clinical microbiology.

Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965)

R. Jones, A. Barry, P. Fuchs, 1986, Journal of clinical microbiology.

Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.

G. Doern, J. Jorgensen, C. Thornsberry, 1986, Diagnostic microbiology and infectious disease.

Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study

L. Reller, R. Jones, A. Barry, 1981, Journal of clinical microbiology.

3-0-demethyl fortimicin A: In vitro activity and interpretive zone standards for disk diffusion susceptibility tests

R. Jones, A. Barry, C. Thornsberry, 1984, European Journal of Clinical Microbiology.

Proposed zone standards for interpretation of fortimicin A disk diffusion tests

R. Jones, A. Barry, C. Thornsberry, 1983, Journal of clinical microbiology.

Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin

R. Jones, A. Barry, C. Thornsberry, 1980, Antimicrobial Agents and Chemotherapy.

Interpretation of the Disk Diffusion Susceptibility Test for Amikacin: Report of a Collaborative Study

J. Washington, P. Yu, C. Thornsberry, 1979, Antimicrobial Agents and Chemotherapy.

Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretation.

R. Jones, A. Barry, C. Thornsberry, 1981, American journal of clinical pathology.

Mechanism of aminoglycoside resistance among beta-lactam-resistant Escherichia coli in the United States.

R. Gaynes, J. Hughes, R. Cooksey, 1987, Diagnostic microbiology and infectious disease.

Netilmicin disk susceptibility tests: Effect of cations on the MIC correlates

R. Jones, A. Barry, C. Thornsberry, 1987, European Journal of Clinical Microbiology.

Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo

R. Jones, R. Ferraresi, A. Barry, 1987, Antimicrobial Agents and Chemotherapy.

Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks

R. Jones, A. Barry, C. Thornsberry, 1982, Journal of clinical microbiology.

Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test

R. Jones, A. Barry, C. Thornsberry, 1981, Antimicrobial Agents and Chemotherapy.

Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks

R. Jones, A. Barry, C. Thornsberry, 1980, Antimicrobial Agents and Chemotherapy.

RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria.

L. Ayers, R. Jones, A. Barry, 1987, Diagnostic microbiology and infectious disease.

Antimicrobial Susceptibility Tests: Automation and Mechanization

C. Thornsberry, C. Thornsberry, 1985 .

In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agents.

L. Ayers, R. Jones, A. Barry, 1986, Diagnostic microbiology and infectious disease.

Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits.

R. Jones, A. Barry, P. Fuchs, 1985, Diagnostic microbiology and infectious disease.

A survey of ciprofloxacin and 11 other antimicrobial agent susceptibility data of United States bacterial isolates from 1990 to 1992

C. Thornsberry, Y. Yee, 1995 .

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Antimicrobial Agents and Chemotherapy.

Evaluation of the MICUR system for quantitative antimicrobial susceptibility testing: a multiphasic comparison with reference methods

R. Jones, A. Barry, C. Thornsberry, 1982, Journal of clinical microbiology.

In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains

R. Jones, C. Baker, C. Thornsberry, 1980, Antimicrobial Agents and Chemotherapy.

Effect of culture medium and carbon dioxide concentration on growth of anaerobic bacteria commonly encountered in clinical specimens.

V. R. Dowell, C. Thornsberry, D. Stalons, 1974, Applied microbiology.

Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin

A. Barry, C. Thornsberry, T. Gavan, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Evaluation of the Sceptor microdilution antibiotic susceptibility testing system: a collaborative investigation

R. Jones, A. Barry, C. Thornsberry, 1981, Journal of clinical microbiology.

Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards

R. Jones, A. Barry, P. Fuchs, 1989, Journal of clinical microbiology.

Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, beta-lactamase stability, and inhibition.

R. Jones, A. Barry, P. Fuchs, 1982, The Journal of antimicrobial chemotherapy.

Evaluation of teicoplanin and vancomycin disk susceptibility tests

R. Jones, A. Barry, C. Thornsberry, 1986, Journal of clinical microbiology.

Susceptibility tests for sulfamethoxazole-trimethoprim by a broth microdilution procedure

C. Thornsberry, J. Swenson, 2007, Current Microbiology.

Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.

R. Jones, A. Barry, P. Fuchs, 1977, The Journal of antibiotics.

Rifampin: spectrum of antibacterial activity.

L. Mcdougal, C. Thornsberry, J. Swenson, 1983, Reviews of infectious diseases.

Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae.

T. O'Brien, A. Barry, J. Matsen, 1976, The Journal of infectious diseases.

Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid

R. Jones, A. Barry, P. Fuchs, 1984, Journal of clinical microbiology.

Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.

R. Jones, A. Barry, P. Fuchs, 1981, The Journal of antimicrobial chemotherapy.

Antimicrobial Susceptibility of Haemophilus influenzae

C. Thornsberry, L. A. Kirven, 1974, Antimicrobial Agents and Chemotherapy.

Disk Diffusion Susceptibility Test Troubleshooting Guide

J. Miller, C. Baker, C. Thornsberry, 1984 .

Clinical laboratory evaluation of the Abbott MS-2 automated antimicrobial susceptibility testing system: report of a collaborative study

L. R. Mccarthy, J. Sherris, J. Washington, 1980, Journal of clinical microbiology.

Methicillin-resistant (hetero-resistant) staphylococci

C. Thornsberry, 1984 .

Microplate phosphocellulose binding assay for aminoglycoside-modifying enzymes

B. Metchock, R. Cooksey, C. Thornsberry, 1986, Antimicrobial Agents and Chemotherapy.

Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy.

R. Jones, A. Barry, C. Thornsberry, 1982, Reviews of infectious diseases.

Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity.

R. Jones, C. Thornsberry, 1982, Reviews of infectious diseases.

Cefmenoxime (SCE-1365), a new Cephalosporin: In Vitro Activity, Comparison with Other Antimicrobial Agents, Beta-Lactamase Stability, and Disk Diffusion Testing with Tentative Interpretive Criteria

Ronald N. Jones, A. Barry, P. Fuchs, 1981, Antimicrobial Agents and Chemotherapy.

Antimicrobial Susceptibility Tests for Streptococcus pneumoniae

C. Thornsberry, J. Swenson, 1980 .

Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.

R. Jones, A. Barry, C. Thornsberry, 1986, Diagnostic microbiology and infectious disease.

In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.

R. Jones, A. Barry, C. Thornsberry, 1980, Cleveland Clinic quarterly.

In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosides.

R. Jones, A. Barry, C. Thornsberry, 1980, The Journal of antimicrobial chemotherapy.

Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin

R. Jones, A. Barry, P. Fuchs, 1985, Antimicrobial Agents and Chemotherapy.

Ceftriaxone: A summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-μg disks

Ronald N. Jones, A. Barry, C. Thornsberry, 1983 .

Tentative interpretive standards for disk susceptibility tests with moxalactam (LY127935)

R. Jones, A. Barry, C. Thornsberry, 1980, Antimicrobial Agents and Chemotherapy.

Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test.

R. Jones, A. Barry, C. Baker, 1980, Clinical therapeutics.

Proposed Quality Control Guidelines

Ronald N. Jones, A. Barry, C. Thornsberry, 2016 .

Cefoperazone: Spectrum of Antibacterial Activity and Disc Diffusion Testing

R. Jones, C. Thornsberry, 2012, Drugs.

In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and β-lactamase studies

Ronald N. Jones, A. Barry, C. Thornsberry, 1985 .

Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strains.

R. Jones, A. Barry, P. Fuchs, 1984, Diagnostic microbiology and infectious disease.

In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits

A L Barry, R N Jones, T L Gavan, 1983, Antimicrobial Agents and Chemotherapy.

Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone

R. Jones, A. Barry, C. Baker, 1982, Journal of clinical microbiology.

Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits

R. Jones, A. Barry, D. Gibbs, 1982, Journal of clinical microbiology.

BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins.

R. Jones, A. Barry, P. Fuchs, 1977, The Journal of antibiotics.

β-Lactam antibiotics: The first- and second-generation cephalosporins

R. Jones, D. Sahm, C. Thornsberry, 1985 .

In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001.

J. Karlowsky, M. Jones, D. Sahm, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Influence ofCation Supplements on Activity ofNetilmicin against Pseudomonas aeruginosa InVitro andInVivo

Ronald N. Jones, R. Ferraresi, C. Thornsberry, 1987 .

Chloramphenicol and penicillin resistance in pneumococci isolated from blood and cerebrospinal fluid: a prevalence study in metropolitan Denver

G. Istre, R. Hopkins, C. Thornsberry, 1983, Journal of clinical microbiology.

In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination

R. Jones, A. Barry, C. Thornsberry, 1987, Journal of clinical microbiology.

Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria

C Thornsberry, D. Culver, D H Culver, 1991, Journal of clinical microbiology.

Evaluation of the MicroScan antimicrobial susceptibility system with the autoSCAN-4 automated reader

D. Rhoden, C. Baker, C. Thornsberry, 1986, Journal of clinical microbiology.

Characteristics of coagulase-negative staphylococci that help differentiate these species and other members of the family Micrococcaceae

W. Jarvis, C. Thornsberry, G. Hancock, 1988, Journal of clinical microbiology.

Biotyping coagulase-negative staphylococci

R. Cooksey, N. Clark, W. Jarvis, 1988, Journal of clinical microbiology.

Characteristics ofCoagulase-Negative Staphylococci ThatHelp Differentiate TheseSpecies andOtherMembers oftheFamily Micrococcaceae

C. Thornsberry, 1988 .

Annals of Clinical Microbiology and Antimicrobials Open Access Emerging Resistance among Bacterial Pathogens in the Intensive Care Unit – a European and North American Surveillance Study (2000–2002) Intensive-care Unitantibiotic Susceptibility

R. Wenzel, J. Karlowsky, D. Sahm, 2022 .

NCCLS Standards for Antimicrobial Susceptibility Tests

C. Thornsberry, 1983 .

Evaluation of the BIOGRAM antimicrobial susceptibility test system

M. Gradus, D. Cleri, J. Vernaleo, 1985, Journal of clinical microbiology.

Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the United States, measured by two methods.

C. Thornsberry, Y. Yee, 1996, The American journal of medicine.

In-vitro activity of cefepime and other antimicrobials: survey of European isolates.

S. Brown, C. Thornsberry, Y. Yee, 1993, The Journal of antimicrobial chemotherapy.

Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines

R. Jones, A. Barry, C. Thornsberry, 1983, Journal of clinical microbiology.

Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.

A. Evangelista, D. Sahm, C. Thornsberry, 2008, Postgraduate medicine.

Susceptibility of Xanthomonas (Pseudomonas) Maltophilia to antimicrobial agents: Methodological Problems

B. Metchock, C. Thornsberry, 1989 .

The development of antimicrobial resistance in staphylococci.

C. Thornsberry, 1988, The Journal of antimicrobial chemotherapy.

Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid

L. Ayers, R. Jones, A. Barry, 1984, Antimicrobial Agents and Chemotherapy.

Decrease in antibiotic susceptibility or increase in resistance?

R. Walker, C. Thornsberry, 1998, The Journal of antimicrobial chemotherapy.

The activity of a combination of penicillin and novobiocin against bovine mastitis pathogens: development of a disk diffusion test.

J. Watts, C. Thornsberry, Y. Yee, 1997, Journal of dairy science.

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998.

M. Jones, D. Sahm, C. Thornsberry, 2000, The Journal of antimicrobial chemotherapy.

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.

M. Jones, D. Sahm, Mark E. Jones, 1999, The Journal of antimicrobial chemotherapy.

Comparative Activity of Cefditoren and Other Oral β-Lactams against Nonpneumococcal Streptococci

J. Karlowsky, D. Sahm, I. Critchley, 2001, Chemotherapy.

Rheumatic fever chemoprophylaxis and penicillin-resistant gingival organisms.

N. Wenger, W. Spencer, C. Thornsberry, 1970, Annals of internal medicine.

Colonization of human wounds by Escherichia vulneris and Escherichia hermannii

J. J. Farmer, C. Thornsberry, J. Swenson, 1985, Journal of clinical microbiology.

Standardization of Broth Microdilution and Disk Diffusion Susceptibility Tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: Quality Control Standards for Ceftiofur, Enrofloxacin, Florfenicol, Gentamicin, Penicillin, Tetracycline, Tilmicosin, and Trimethoprim-Sulfamethoxazole

P. McDermott, G. Stein, R. Jones, 2001, Journal of Clinical Microbiology.

In vitro evaluation of A-56619 and A-56620, two new quinolones

A L Barry, R N Jones, C Thornsberry, 1986, Antimicrobial Agents and Chemotherapy.

Activity of pirlimycin against pathogens from cows with mastitis and recommendations for disk diffusion tests

J. Watts, C. Thornsberry, R. Yancey, 1993, Antimicrobial Agents and Chemotherapy.

Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin

R. Jones, A. Barry, C. Baker, 1980, Antimicrobial Agents and Chemotherapy.

Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics

R. Jones, A. Barry, C. Baker, 1980, Antimicrobial Agents and Chemotherapy.

1-N-(S-3-amino-2-hydroxypropionyl) gentamicin B (Sch 21420): A collaborative in vitro susceptibility comparison with amikacin and gentamicin against 12,984 clinical bacterial isolates

Ronald N. Jones, A. Barry, P. Fuchs, 1978, Current Microbiology.

In Vitro Evaluation of HR810, a New Wide-Spectrum Aminothiazolyl α-Methoxyimino Cephalosporin

Ronald N. Jones, A. Barry, C. Thornsberry, 1984, Antimicrobial Agents and Chemotherapy.

In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs

R. Jones, A. Barry, C. Thornsberry, 1983, Antimicrobial Agents and Chemotherapy.

In Vitro Antibacterial Properties of Pexiganan, an Analog of Magainin

K. Holroyd, H. Wexler, C. Thornsberry, 1999, Antimicrobial Agents and Chemotherapy.

Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates

R. Jones, A. Barry, P. Fuchs, 1977, The American journal of the medical sciences.

BL-S786, A NEW PARENTERAL CEPHALOSPORIN. I

Ronald N. Jones, A. Barry, P. Fuchs, 1977 .

Cefpiramide: comparative in-vitro activity and β-lactamase stability

Ronald N. Jones, L. Ayers, A. Barry, 1985 .

In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin

R. Jones, A. Barry, C. Thornsberry, 1984, Antimicrobial Agents and Chemotherapy.

The In Vitro Antibacterial Activity of Quinolones: A Review

C. Thornsberry, 1998 .

Sch 29482, a new oral penem: comparative in-vitro activity, beta-lactamase stability and inhibition.

R. Jones, A. Barry, C. Thornsberry, 1982, The Journal of antimicrobial chemotherapy.

Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics.

R. Jones, A. Barry, P. Fuchs, 1979, American journal of clinical pathology.

Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidis.

R. Jones, A. Barry, P. Fuchs, 1979, The Journal of antibiotics.

In Vitro Activity of Rosamicin, Josamycin, Erythromycin, and Clindamycin Against β-Lactamase-Negative and β-Lactamase-Positive Strains of Neisseria gonorrhoeae

C. Thornsberry, J. Biddle, 1979, Antimicrobial Agents and Chemotherapy.

Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories

L. Ayers, R. Jones, A. Barry, 1984, Journal of clinical microbiology.

Antimicrobial Surveillance of Haemophilus influenzae in the United States during 2000-2001 Leads to Detection of Clonal Dissemination of a β-Lactamase-Negative and Ampicillin-Resistant Strain

J. Karlowsky, D. Sahm, I. Critchley, 2002, Journal of Clinical Microbiology.

Penicillin-resistant Streptococcus pneumoniae on the rise in the United States: Its effect on oral cephalosporins

C. Thornsberry, Y. Yee, 1994 .

Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.

R. Jones, A. Barry, C. Thornsberry, 1985, Reviews of infectious diseases.

β-Lactamase of the Legionnaires' bacterium

C. Thornsberry, L. A. Kirven, 2007, Current Microbiology.

Relationship between in vitro susceptibility test results for chloramphenicol and production of chloramphenicol acetyltransferase by Haemophilus influenzae, Streptococcus pneumoniae, and Aerococcus species

C. Baker, C. Thornsberry, H. Matthews, 1988, Journal of clinical microbiology.

Cefuroxime, an in vitro Comparison with Six Other Cephalosporins

R. Jones, A. Barry, P. Fuchs, 1977, Proceedings of the Royal Society of Medicine.

In-vitro bactericidal synergism of rifampicin and trimethoprim and implications for treatment of carriers of Haemophilus influenzae.

L. Mcdougal, C. Thornsberry, 1982, The Journal of antimicrobial chemotherapy.

Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria

A L Barry, R N Jones, T L Gavan, 1987, Journal of clinical microbiology.

Ampicillin-resistant Haemophilus influenzae. 1. Incidence, mechanism, and detection.

L. Mcdougal, C. Thornsberry, 1982, Postgraduate medicine.

Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.

L. Ayers, R. Jones, A. Barry, 1987, Diagnostic microbiology and infectious disease.

The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.

R. Jones, A. Barry, C. Thornsberry, 1985, American Journal of Clinical Pathology.

In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent

R. Jones, A. Barry, W. J. Novick, 1982, Journal of clinical microbiology.

Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests

R. Jones, A. Barry, C. Thornsberry, 1984, Journal of clinical microbiology.

Evaluation of the cefonicid disk test criteria, including disk quality control guidelines

R. Jones, A. Barry, C. Thornsberry, 1983, Journal of clinical microbiology.

Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disks

R. Jones, A. Barry, C. Thornsberry, 1984, Journal of clinical microbiology.

Quality control limits for microdilution susceptibility tests with norfloxacin

L. Ayers, A. Barry, P. Fuchs, 1987, Journal of clinical microbiology.

Cefaclor AF: correlation of microbiology and clinical outcome.

C. Thornsberry, 1992, Postgraduate medical journal.

Ampicillin-resistant Haemophilus influenzae. 2. Therapeutic considerations.

L. Mcdougal, C. Thornsberry, L. McDougal, 1982, Postgraduate medicine.

Trends in Ciprofloxacin Nonsusceptibility and Levofloxacin Resistance among Streptococcus pneumoniae Isolates in North America

J. Karlowsky, M. Jones, D. Sahm, 2001, Journal of Clinical Microbiology.

In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin

R. Jones, A. Barry, C. Thornsberry, 1981, Antimicrobial Agents and Chemotherapy.

Antimicrobial resistance trends among sinus isolates of Streptococcus pneumoniae in the United States (2001–2005)

A. Evangelista, M. Benninger, D. Sahm, 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

β-lactam antibiotics: The extended spectrum penicillins

R. Jones, D. Sahm, C. Thornsberry, 1985 .

BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.

R. Jones, A. Barry, P. Fuchs, 1977, The Journal of antibiotics.

Factors influencing fluoroquinolone resistance.

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Emerging infectious diseases.

Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.

R. Jones, A. Barry, C. Baker, 1979, The Journal of antibiotics.

Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin

R. Jones, A. Barry, P. Fuchs, 1986, Journal of clinical microbiology.

Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae.

P. Murray, R. Jones, J. Washington, 1990, Diagnostic microbiology and infectious disease.

The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.

R. Jones, A. Barry, P. Fuchs, 1986, American journal of clinical pathology.

International Surveillance of Susceptibility to Levofloxacin and Other Agents among Respiratory Pathogens

M. Jones, D. Sahm, I. Critchley, 1999, Drugs.

Activity of cefditoren against beta-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalis.

J. Karlowsky, D. Sahm, I. Critchley, 2002, Diagnostic microbiology and infectious disease.

Antimicrobial Susceptibility Patterns of Streptococcus pneumoniae

R. Cooksey, R. Facklam, C. Thornsberry, 1978, Antimicrobial Agents and Chemotherapy.

Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.

D. Sahm, Mark E. Jones, C. Thornsberry, 2008, Postgraduate medicine.

Antimicrobial susceptibility testing of nonenterococcal streptococci

Ronald N. Jones, C. Thornsberry, J. Swenson, 1986 .

In vitro antimicrobial activity of piperacillin and seven other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase producing strains.

R. Jones, C. Baker, C. Thornsberry, 1979, The Journal of antimicrobial chemotherapy.

Inhibition of β-Lactamase in Neisseria gonorrhoeae by Sodium Clavulanate

J. Miller, C. Baker, C. Thornsberry, 1978, Antimicrobial Agents and Chemotherapy.

Inhibition of beta-lactamase in Neisseria gonorrhoeae by sodium clavulanate.

J. Miller, C. Baker, C. Thornsberry, 1978, Antimicrobial agents and chemotherapy.

Antimicrobial resistance in pneumococci from the USA: Are there trends?

R. Facklam, C. Thornsberry, J. Swenson, 1988 .

Prevalence of Oxacillin Resistance in Staphylococcus aureus among Inpatients and Outpatients in the United States during 2000

J. Karlowsky, D. Sahm, Mark E. Jones, 2002, Antimicrobial Agents and Chemotherapy.

Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testing

R. Jones, A. Barry, P. Fuchs, 1981, Antimicrobial Agents and Chemotherapy.

Trends in Antimicrobial Resistance Among Today's Bacterial Pathogens

C. Thornsberry, 1995, Pharmacotherapy.

Vancomycin resistant streptococci? probably not

R. Facklam, C. Thornsberry, 1984 .

Tentative disk diffusion susceptibility interpretive criteria for pefloxacin

R. Jones, A. Barry, P. Fuchs, 1986, Journal of clinical microbiology.

Antimicrobial Susceptibility of Subgingival Bacterial Flora in Cats with Gingivitis

F. Shofer, C. Thornsberry, C. Harvey, 1995, Journal of veterinary dentistry.

Apalcillin (PC-904): Spectrum of activity and β-lactamase hydrolysis/inhibition

Ronald N. Jones, A. Barry, C. Thornsberry, 1985 .

Interpretive Criteria for Antimicrobial Susceptibility Testing of Ceftiofur against Bacteria Associated with Swine Respiratory Disease

J. Watts, C. Thornsberry, Y. Yee, 1996, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Review, Comments, and Opinions

C. Thornsberry, 1991, The Annals of otology, rhinology & laryngology. Supplement.

Antimicrobial Resistance among Respiratory Pathogens Collected in Thailand during 1999-2000

A. Vibhagool, J. Karlowsky, D. Sahm, 2002, Journal of chemotherapy.

Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillins.

R. Jones, A. Barry, P. Fuchs, 1977, The Journal of antibiotics.

Piperacillin susceptibility tests by the single-disk agar diffusion technique

R. Jones, A. Barry, C. Baker, 1979, Antimicrobial Agents and Chemotherapy.

Review of the in vitro antibacterial activity of cefprozil, a new oral cephalosporin.

C. Thornsberry, 1992, Clinical Infectious Diseases.

In vitro Inhibition of Migration of Leukocytes by Old Tuberculin (OT) as an Indicator of Active Tuberculosis.

C. Thornsberry, E. Gerlach, M. Schesago, 1964 .